Insilico Medicine Reports Successful Phase 1 Trials of ISM5411 for IBD Insilico Medicine announces positive Phase I trial results for ISM5411, a new AI-designed drug for treating inflammatory bowel disease, showing safety and efficacy.

Insilico Medicine Reports Successful Phase 1 Trials of ISM5411 for IBD #United_States #Cambridge #Inflammatory_Bowel_Disease #Insilico_Medicine #ISM5411